Funding for this research was provided by:
Text and Data Mining valid from 2019-08-14
Received: 13 June 2019
Accepted: 8 August 2019
First Online: 14 August 2019
Ethics approval and consent to participate
: The study was approved by the Ethical Committee of the University Hospital of Padova (No. 3302/AO/14). All participants signed a written informed consent.
: Not applicable.
: B.M.B. received lecture or advisory board fees from Astra Zeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk and Novartis, G.P.F. received grant support, lecture fees, or advisory board fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi, Genzyme, Abbott, Novartis, and Merck Sharp & Dohme. A.A. received research grants, lecture fees, or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Eli Lilly, Servier, and Takeda. The remaining authors have nothing to disclose.